Anzeige
Mehr »
Samstag, 13.09.2025 - Börsentäglich über 12.000 News
Investment Idee: Einsteigen bevor sich die Schleuse öffnet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DSFQ | ISIN: JE00BPG99318 | Ticker-Symbol:
NASDAQ
12.09.25 | 21:58
1,810 US-Dollar
+1,12 % +0,020
Branche
Kosmetik
Aktienmarkt
Sonstige
1-Jahres-Chart
WALDENCAST PLC Chart 1 Jahr
5-Tage-Chart
WALDENCAST PLC 5-Tage-Chart

Aktuelle News zur WALDENCAST Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiWaldencast Says Obagi Saypha MagIQ Injectable Hyaluronic Acid Gel Approved In U.S.-
MiWaldencast plc - 6-K, Report of foreign issuer1
MiWaldencast plc: Waldencast Announces FDA Approval of Obagi saypha MagIQ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand425LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration ("FDA") has...
► Artikel lesen
20.08.Waldencast Delays Earnings Release, Launches Strategic Review4
20.08.Waldencast Reports H1 2025 Brand Growth, Acquires Novaestiq, and Reviews Strategic Options1
18.08.Waldencast plc: Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation835Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand's Addressable Market in the U.S. Milk Makeup Delivers Strong Retail Sales...
► Artikel lesen
WALDENCAST Aktie jetzt für 0€ handeln
18.08.Waldencast plc - 6-K, Report of foreign issuer2
18.08.Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts3
25.07.Waldencast Doubles Down on Aesthetics with Novaestiq Acquisition and U.S. Rights to Saypha® Injectable Line1
23.07.Croma Pharma: Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast780Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions LEOBENDORF, Austria, July 23, 2025 /PRNewswire/...
► Artikel lesen
23.07.Waldencast expandiert durch Übernahme von Novaestiq in den Markt für Injektionsmittel4
23.07.Waldencast acquires Novaestiq to expand Obagi Medical into injectables2
23.07.Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast546Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio SOUTHLAKE, TX / ACCESS Newswire / July 23, 2025 / Gore Range Capital (GRC) announced...
► Artikel lesen
23.07.Waldencast plc - 6-K, Report of foreign issuer1
23.07.Waldencast plc: Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha, Under the Obagi Medical Brand451Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics...
► Artikel lesen
05.06.Waldencast Opens Dubai Hub to Drive Middle East Growth2
15.05.Canaccord cuts Waldencast price target to $5, maintains Buy1
14.05.Waldencast reports Q1 results18
14.05.Waldencast Q1 2025 slides: Mixed brand performance amid retail expansion push1
13.05.Waldencast plc.: Waldencast Reports Q1 2025 Financial Results1.176Q1 Net Revenue of $65.4 million, (4.1)% decline from Q1 202476.4% Adjusted Gross Margin, an improvement of 10 basis points$4.4 million of Adjusted EBITDA LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Waldencast...
► Artikel lesen
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1